Therapeutic Outcome of Endocrine Disorders

CHF 106.75
Auf Lager
SKU
EH2EBHIG41R
Stock 1 Verfügbar
Geliefert zwischen Do., 30.04.2026 und Fr., 01.05.2026

Details

Therapeutic Outcome of Endocrine Disorders: Efficacy, Innovation and Quality of Life presents the proceedings of an international symposium held from November 13-16, 1997 in Palm Beach Gardens, Florida. The proceedings discuss scientific and clinical studies related to the treatment of endocrine disorders.

Inhalt

  1. Outcome Research in Pediatric Psychoendocrinology and Sexology.- I. Treatment of Growth Hormone Deficiency: Efficacy, Innovation and Quality of Life.- 2. Growth Hormone Replacement in Adults: The First 10 Years.- 3. Quality of Life in Children and Adults with Growth Hormone Deficiency.- 4. Treatment of Childhood Growth Hormone Deficiency: Efficacy and Innovation.- 5. Quality of Life Among Adults with Childhood Onset Growth Hormone Deficiency: A Comparison with Siblings.- 6. Quality of Life in Adults with Growth Hormone Deficiency Diagnosed During Childhood (An Invited Contribution).- II. Treatment of Turner Syndrome: Efficacy, Innovation and Quality of Life.- 7. The Impact of Growth Hormone Therapy on Turner Syndrome.- 8. Phenotype-Karyotype Relationships in Turner Syndrome.- 9. Standards of Care Needed to Optimize Outcomes for Turner Syndrome.- III. Treatment of Short, Non-Growth Hormone Deficiency: Efficacy, Innovation and Quality of Life.- 10. The Non-Growth Hormone-Deficient Child: Does Therapy with Growth Hormone Produce Benefit?.- 11. Impact of Short Stature on Quality of Life: Where Is the Evidence?.- 12. Mediators of Psychological Adjustment in Children and Adolescents with Short Stature (An Invited Contribution).- 13. Turner Syndrome: Psychological Functioning Rated Parents and by the Girls Themselves (An Invited Contribution).- IV. Treatment of Diabetes: Efficacy, Innovation and Quality of Life.- 14. Evaluating Quality of Life in Diabetes: Methods and Findings.- 15. Effective Utilization of Self-Monitored Blood Glucose Data: Cognitive and Behavioral Prerequisites.- 16. Influence of Type 1 Diabetes on Childhood Growth and Development.- 17. Glycosylated Hemoglobin: A Myopic View of Diabetes Care?.- V. Treatment of Congenital Adrenal Hyperplasia: Efficacy, Innovation and Quality of Life.- 18. Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency (Salt-Losing Form and Simple Virilizing Form): Long-Term Results of Treatment.- 19. Psychological Outcome in Congenital Adrenal Hyperplasia.- 20. Psychosexual Quality of Life in Adult Intersexuality: The Example of Congenital Adrenal Hyperplasia (CAH) (An Invited Contribution).- 21. Male Fertility in Congenital Adrenal Hyperplasia (An Invited Contribution).- VI. Treatment of Congenital Hypothyroidism: Efficacy, Innovation and Quality of Life.- 22. Growth and Development of Hypothyroid Infants.- 23. Neurobehavioral Consequences of Congenital Hypothyroidism Identified by Newborn Screening.- Author Index.

Weitere Informationen

  • Allgemeine Informationen
    • Sprache Englisch
    • Editor Brian Stabler, Barry B. Bercu
    • Titel Therapeutic Outcome of Endocrine Disorders
    • Veröffentlichung 23.10.2012
    • ISBN 1461270529
    • Format Kartonierter Einband
    • EAN 9781461270522
    • Jahr 2012
    • Größe H235mm x B155mm x T17mm
    • Untertitel Efficacy, Innovation and Quality of Life
    • Gewicht 452g
    • Auflage Softcover reprint of the original 1st ed. 2000
    • Genre Medizin
    • Lesemotiv Verstehen
    • Anzahl Seiten 296
    • Herausgeber Springer
    • GTIN 09781461270522

Bewertungen

Schreiben Sie eine Bewertung
Nur registrierte Benutzer können Bewertungen schreiben. Bitte loggen Sie sich ein oder erstellen Sie ein Konto.
Made with ♥ in Switzerland | ©2025 Avento by Gametime AG
Gametime AG | Hohlstrasse 216 | 8004 Zürich | Schweiz | UID: CHE-112.967.470
Kundenservice: customerservice@avento.shop | Tel: +41 44 248 38 38